Quote:

---

remember my post dated july 13,2020

"at 16:47 in cc call dr kelly said cydy was in potential partnership discussions with 5 worldwide pharmaceutical companies as well as discussions with companies in brazil,china,india,europe,middle east, and north africa.."

---

I honestly don't remember your post, but I have included this information in my Catalyst List ever since that call.

EDIT: After reading follow-ups to your post.

If those opportunities are real and alive, and have not gone the way of the several deals Dr.NP discussed as being "in-process" earlier this year, I'm not sure we'll hear anything about them before the S/C read-out. The only caveat in my mind would be an ex-US approval of the M/M indication -- as that would likely require a global distribution deal.